BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2859620)

  • 21. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives].
    Kostowski W; Płaźnik A
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340
    [No Abstract]   [Full Text] [Related]  

  • 22. The GABA-ergic system: a locus of benzodiazepine action.
    Tallman JF; Gallager DW
    Annu Rev Neurosci; 1985; 8():21-44. PubMed ID: 2858999
    [No Abstract]   [Full Text] [Related]  

  • 23. The GABAA/benzodiazepine receptor: implications for the molecular basis of anxiety.
    Breier A; Paul SM
    J Psychiatr Res; 1990; 24 Suppl 2():91-104. PubMed ID: 1980704
    [No Abstract]   [Full Text] [Related]  

  • 24. Decreased sensitivity to benzodiazepine receptor agonists and increased sensitivity to inverse agonists following chronic treatments: evidence for separate mechanisms.
    Stephens DN; Schneider HH; Weidmann R; Zimmermann L
    Adv Biochem Psychopharmacol; 1988; 45():337-54. PubMed ID: 2459923
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of adenosine in the central actions of the benzodiazepines.
    Phillis JW; O'Regan MH
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):389-404. PubMed ID: 2900536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary on the mode of action of benzodiazepines.
    Leonard BE
    J Psychiatr Res; 1993; 27 Suppl 1():193-207. PubMed ID: 7908333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of methyl- and propyl-beta-carbolines in a hereditary model of epilepsy.
    Johnson DD; Fisher TE; Tuchek JM; Crawford RD
    Neuropharmacology; 1984 Sep; 23(9):1015-7. PubMed ID: 6151141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic drug targets: beyond the usual suspects.
    Gordon JA
    J Clin Invest; 2002 Oct; 110(7):915-7. PubMed ID: 12370268
    [No Abstract]   [Full Text] [Related]  

  • 29. [Esters of beta-carboline-3-carboxylic acids with alicyclic alcohols--synthesis and benzodiazepine receptor affinity].
    Geldsetzer KH; Schunack W
    Arch Pharm (Weinheim); 1990 Jan; 323(1):9-12. PubMed ID: 1970720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurobiologic basis of anxiety and its treatment.
    Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
    Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of benzodiazepine antagonists.
    Haefely W
    Pharmacopsychiatry; 1985 Jan; 18(1):163-6. PubMed ID: 2859619
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of flumazenil, Ro 154513 and beta-CCM on the behaviour of control and stressed mice in the staircase test.
    Pokk P; Väli M
    J Psychopharmacol; 2001 Sep; 15(3):155-9. PubMed ID: 11565621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of interference with the speed and accuracy of escape produced by inescapable shock.
    Maier SF; Minor TR
    Behav Neurosci; 1993 Feb; 107(1):139-46. PubMed ID: 8383499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation.
    Stephens DN; Turski L; Jones GH; Steppuhn KG; Schneider HH
    Psychopharmacol Ser; 1993; 11():79-95. PubMed ID: 7908435
    [No Abstract]   [Full Text] [Related]  

  • 35. Is tofisopam an atypical anxiolytic?
    Pellow S; File SE
    Neurosci Biobehav Rev; 1986; 10(2):221-7. PubMed ID: 2874535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic behavioural actions of n-propyl beta-carboline-3-carboxylate.
    File SE; Lister RG; Maninov R; Tucker JC
    Neuropharmacology; 1984 Apr; 23(4):463-6. PubMed ID: 6547213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that the beta-carboline, ZK 91296, can reduce anxiety in animals at doses well below those causing sedation.
    Pellow S; File SE
    Brain Res; 1986 Jan; 363(1):174-7. PubMed ID: 2868775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proconvulsant and diazepam-reversing effects of ethyl-beta-carboline-3-carboxylate.
    Oakley NR; Jones BJ
    Eur J Pharmacol; 1980 Dec; 68(3):381-2. PubMed ID: 6110548
    [No Abstract]   [Full Text] [Related]  

  • 39. Anxiety: its generation by drugs and by their withdrawal.
    Dorow R; Duka T
    Adv Biochem Psychopharmacol; 1986; 41():211-25. PubMed ID: 2874694
    [No Abstract]   [Full Text] [Related]  

  • 40. Stress controllability influences the ataxic properties of both ethanol and midazolam in the rat.
    Drugan RC; Coyle TS; Healy DJ; Chen S
    Behav Neurosci; 1996 Apr; 110(2):360-7. PubMed ID: 8731063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.